Document:

Unassociated Document

    CHANGE
      IN CONTROL AGREEMENT

     

    This
      CHANGE IN CONTROL AGREEMENT (the "Agreement") is
      made
      on of this 19th day
      of
      February, 2008 by and among UNION CENTER
      NATIONAL BANK, a bank chartered under the laws of Congress (the "Bank"),
CENTER
      BANCORP INC., a New Jersey corporation that owns all of the capital stock of
      the
Bank
      (the
      "Company") and A. RICHARD ABRAHAMIAN ("EMPLOYEE").

    

    BACKGROUND:

    WHEREAS,
      EMPLOYEE is currently employed as a Senior Vice President of the Bank and
as
      a Vice
      President of the Company; and

     

    WHEREAS,
      the Boards of Directors of the Bank and the Company believe it is imperative
      that the Bank and the Company be able to rely upon EMPLOYEE to continue in
      his
position
      in the event that the Bank or the Company receives any proposal from a third
      person concerning
      a possible acquisition of the equity securities or assets of the Bank or the
      Company, and
      that
      the Bank and the Company be able to receive and rely upon EMPLOYEE's advice,
      if
      they request
      it, as to the best interests of the Company, the Bank and their respective
      shareholders, without
      concern that EMPLOYEE might be distracted by the personal uncertainties and
      risks created
      by such a proposal; and

     

    WHEREAS,
      to achieve that goal, and to retain EMPLOYEE's services prior to any such
      activity, the Bank, the Company and EMPLOYEE have agreed to enter into this
      Agreement to govern
      EMPLOYEE's termination benefits in the event of a Change in Control Event (as
      defined below).

     

    NOW,
      THEREFORE, in consideration of the foregoing premises and for other good and
      valuable consideration, the receipt and sufficiency of which is hereby
      acknowledged, the parties hereto hereby agree as follows:

     

    1. Certain
      Definitions:
      As used
      in the Agreement, the following terms shall have the respective meanings set
      forth below:

     

    (a)
      "Cause"
      means
      (i) EMPLOYEE's conviction of, guilty plea to, or confession of
      guilt
      of, any crime that constitutes a felony or criminal act involving moral
      turpitude, (ii) EMPLOYEE's
      commission of a fraudulent, illegal, disloyal or dishonest act in respect of
      the
      Bank or
      the
      Company, (iii) termination of the Bank's business due to unprofitability,
      insolvency, bankruptcy
      or directive by governmental regulators, (iv) EMPLOYEE's willful misconduct
      or
      gross negligence
      that reasonably could be expected to be materially injurious to the business,
      operations,
      or reputation of the Bank and/or the Company, (v) EMPLOYEE's violation of a
      material nature
      of
      the Bank's or the Company's policies or procedures in effect from time to time;
      provided,
      however, to the extent such violation is subject to cure, such violation shall
      not constitute
      "Cause"
      unless
      EMPLOYEE fails to cure such violation within 10 days after written notice
      thereof, (vi) EMPLOYEE's material failure to perform EMPLOYEE's duties as
      assigned to EMPLOYEE
      by the Bank and/or the Company from time to time; provided, however, to the
      extent such failure is subject to cure, such failure shall not constitute
      "Cause" unless EMPLOYEE fails to cure
      such
      failure within 10 days after written notice thereof, or (vii) EMPLOYEE's
      death.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

       

    

    Termination
      for "Cause" shall not be construed to include the takeover of the Bank or the
      Company,
      in either a hostile or voluntary manner, by another person, firm or
      corporation.

     

    (b) "Change
      in Control Event" means (i) the consummation of an acquisition by
      a
      third party of a majority of the voting capital stock of the Company or the
      Bank
      or substantially
      all of the assets of the Company or the Bank or (ii) a change in the composition
      of the
      Board
      of Directors of the Company (the "Board") such that the Continuing Directors
      (as
      hereinafter defined) no longer constitute a majority of the Board.

     

    (c) "Continuing
      Directors" shall mean (i) each current member of the Company's
      Board of Directors and (ii) each person who is hereinafter first nominated
      to
      such Board
      by
      unanimous vote of the persons who then constitute Continuing
      Directors.

     

    (d) "Good
      Reason" means
      the
      resignation by EMPLOYEE within 180 days after the occurrence of a Change in
      Control Event.

     

    (e) "Release"
      means a general release agreement in a form acceptable to the Company and the
      Bank, which Release shall include, among other things, a general release of
      the
      Bank, the Company and related parties from all liability.

     

    (f) "Trigger
      Event" shall mean, the occurrence during the Term (as defined below)
      of
      either: (i) the termination of EMPLOYEE's employment by the Bank and the Company
      (or
      their
      respective successors) upon, or within 12 months following, a Change in Control
      Event, other
      than a termination of EMPLOYEE's employment by the Bank and the Company (or
      their respective
      successors) for Cause; or (ii) EMPLOYEE's resignation for Good Reason, upon,
      or
      within 12 months following, a Change in Control Event, provided that
EMPLOYEE
      delivers written notice of EMPLOYEE's resignation to the Bank and the Company
      (or their
      respective successors ) at least 30 days prior to the effective date of such
      resignation.

     

    2.
       Term
      of Agreement.
      Except
      as otherwise provided in the next sentence of this Section
      2, the term of this Agreement shall be two (2) years, effective as of February
      19, 2008 and terminating
      February 19, 2010(the "Initial Term"). This Agreement
      shall not automatically renew or be automatically extended beyond February
      19,
      2010. Notwithstanding the foregoing, if
      a
      "Change in Control Event" occurs at any time prior to February 19, 2010, then
      the term of this Agreement shall automatically be extended for
      a
      period of one (1) year from the date of such Change in Control Event.
      

     

    3.
       Trigger
      Event Payments and Benefits.

     

    (A) Upon
      the
      occurrence of a Trigger Event (a) subject to EMPLOYEE's execution,
      delivery and non-revocation of the Release, EMPLOYEE shall be entitled to:
      (i) a
      lump sum
      payment equal to the product of (x) three (3) and (y) the sum of (1) EMPLOYEE's
      annual base salary as in effect immediately prior to the Trigger Event, (2)
      the
      largest annual cash bonus ever received by EMPLOYEE from the Bank and/or the
      Company (the "Largest Bonus"), (3) the amount recorded
      on EMPLOYEE's W-2 (for the calendar year preceding the calendar year in which
      the Trigger
      Event occurs) that is attributable to fringe benefits provided to EMPLOYEE
      by
      the Bank and/or
      the Company, and (4) the
      maximum matching contribution that
      could have been made under the Bank's 401(k) plan if EMPLOYEE had remained
      employed by the
      Bank
      and the Company for an additional one (1) year following the Trigger Event
      (the
"Trigger
      Event Payment" and together with the "Pension Trigger Event Payment" described
      in subparagraph
      B below, the "Combined Trigger Event Payments"); and (ii) if EMPLOYEE timely
      elects
      COBRA coverage and provided EMPLOYEE continues to make contributions for such
      continuation
      coverage equal to EMPLOYEE's contribution amount in effect immediately preceding
      the
      date
      of EMPLOYEE's termination of employment, the Bank and/or the Company, as
      applicable, shall
      waive the remaining portion of EMPLOYEE's healthcare continuation payments
      under
COBRA
      for
      an eighteen (18)-month period following the Trigger Event; and (b) all stock
      options granted to EMPLOYEE by the Company shall be exercisable in full,
      effective as of the date of the Trigger
      Event. Notwithstanding the foregoing, in the event that EMPLOYEE becomes
      eligible to obtain alternate healthcare coverage from a new employer before
      the
      18-month anniversary of the
      Trigger Event, the Bank's and/or the Company's obligation to waive the remaining
      portion of EMPLOYEE's
      healthcare continuation coverage under COBRA shall cease. EMPLOYEE understands
      and
      affirms that EMPLOYEE is obligated to inform the Bank and the Company if
      EMPLOYEE becomes
      eligible to obtain alternate healthcare coverage from a new employer before
      the
      18-month
      anniversary of the Trigger Event. In addition, for a period of three years
      following the Trigger
      Event, the Bank and the Company, at their expense, shall continue to provide
      EMPLOYEE with
      life
      insurance coverage commensurate with the coverage that was being provided to
      EMPLOYEE
      immediately prior to EMPLOYEE's date of termination.

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

       

    

    (B) Within
      thirty (30) days following the occurrence of a Trigger Event, the EMPLOYEE
      shall, subject to EMPLOYEE's execution, delivery and non-revocation of the
      Release, also be entitled to a lump sum payment equal to the excess, if any,
      of
      (x) the lump sum present value
      of
      the benefit that the EMPLOYEE would have been entitled to under the Bank's
      tax-qualified
      defined benefit pension plan (the "Pension Plan") had he continued to be
      employed by the
      Bank
      and the Company for an additional three (3) year period following the Triggering
      Event (assuming that he continued during such period to receive a salary equal
      to the salary in effect on the date of the Trigger Event and an annual incentive
      bonus equal to the Largest Bonus), over (y) the
      lump
      sum present value of the benefit that the EMPLOYEE is entitled to under the
      Pension Plan as
      of the
      date of EMPLOYEE's termination of employment. Present value calculations, for
      purposes
      of the foregoing, shall be made in the manner used under the Pension Plan for
      purposes of
      determining lump sum distributions.

     

    (C)
      The
      Trigger Event Payment (less applicable withholdings and deductions) shall
      be
      paid to EMPLOYEE in a lump sum on the next regular payroll date following the
      8th
      day
      after
      EMPLOYEE's execution and delivery of the Release and the Pension Trigger Event
      Payment shall
      be
      paid in accordance with subparagraph B above (but no earlier than the
      8th
      day
      after
EMPLOYEE's
      execution and delivery of the Release); provided, however, that if necessary
      to
comply
      with the restriction in Section 409A(a)(2)(B) of the Internal Revenue Code
      of
      1986, as amended
      (the "Code")
      concerning payments to "specified EMPLOYEEs," the Combined Trigger Event
      Payments shall be made on the first business day of the seventh month following
      the Trigger
      Event. EMPLOYEE shall have no obligation to seek substitute employment or
      otherwise mitigate
      the Bank's and the Company's obligations to make the payments set forth in
      this
Section
      3.

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

       

    

    4. Affects
      of Section 4999
      Excise
      Taxes. Notwithstanding
      any provisions in this Agreement to the contrary, in
      the
      event that either the Company's independent public accountants or the
      Internal Revenue Service determines that any payment, coverage or benefit
      provided to EMPLOYEE
      is subject to the excise tax imposed by Section 4999 (or any successor
      provision) of the
      Code
      ("Section 4999"), the
      EMPLOYEE shall have no right under this Agreement or otherwise to receive all
      or
      any portion of such payment,
      coverage or benefit that if received would result in the imposition of the
      excise tax under Section 4999 (“Excess Benefit”), and neither the Bank nor the
      Company shall have any obligation to pay the EMPLOYEE an Excess Benefit. If
      notwithstanding the foregoing the Bank or the Company pays the EMPLOYEE an
      Excess Benefit, the EMPLOYEE shall promptly repay the Excess Benefit upon notice
      and demand by the Bank or the Company. This Section 4 shall survive termination
      of this Agreement.

     

    5. At
      Will
      Employment. This Agreement shall not affect any rights of the Bank, the
Company
      or the EMPLOYEE prior to a Change in Control Event or any of your rights granted
      in any
      other
      agreement, plan or arrangements, except that if EMPLOYEE receive all payments
      under this
      Agreement, EMPLOYEE shall not be entitled to receive any payments or benefits
      under any other
      severance arrangement (if any) with the Bank or the Company. The rights, duties
      and benefits
      provided under this Agreement only shall become effective upon a Change in
      Control Event.
      Nothing in this Agreement shall alter EMPLOYEE's status as an "at-will"
      EMPLOYEE. If EMPLOYEE's
      employment by the Bank and/or the Company is terminated for any reason prior
      to
      a Change in Control Event, this Agreement shall thereafter be of no further
      force and effect.

     

    6. Headings.
      Headings used in this Agreement are for convenience of reference only
      and
      do not affect the meaning of any provision.

     

    7. Counterparts.
      This Agreement may be executed as of the same effective date in one
      or
      more counterparts, each of which shall be deemed an original.

     

    8. Binding
      Agreement; Assignment. This Agreement shall be binding upon and shall
      inure to the benefit of the parties hereto and their respective successors
      and
      assigns.

     

    9. Governing
      Law; Jurisdiction. This Agreement and any and all matters arising directly
      or indirectly herefrom shall be governed by, and construed in accordance with,
      the internal
      laws of the State of New Jersey, without reference to the choice of law
      principles thereof.
      Any legal action, suit or other proceeding arising out of or in any way
      connected with this
      Agreement shall be brought in the courts of the State of New Jersey, or in
      the
      United States courts
      for the District of New Jersey. With respect to any such proceeding in any
      such
      court: (i) each
      party generally and unconditionally submits itself and its property to the
      exclusive jurisdiction
      of such court (and corresponding appellate courts therefrom), and (ii) each
      party waives, to the fullest extent permitted by law, any objection it has
      or
      hereafter may have the venue
      of
      such proceeding as well as any claim that it has or may have that such
      proceeding is in an
      inconvenient forum.

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

       

    

    10. Amendments.
      This Agreement may only be amended or otherwise modified, and the provisions
      hereof may only be waived, by a writing executed by the parties
      hereto.

     

    11. Entire
      Agreement. This Agreement shall constitute the entire agreement of the
parties
      with respect to the matters covered hereby and shall supersede all previous
      written, oral or
      implied understandings between them with respect to such matters.

     

    12. Opportunity
      to Consult Counsel. EMPLOYEE hereby acknowledges that he has read and
      fully
      understands this Agreement, and
      that
      EMPLOYEE has been advised to,
      and
      has had the opportunity to, consult with counsel and EMPLOYEE's personal
      financial or tax advisor with respect to this Agreement.

     

    13. No
      Effect on Other Benefits.
      Notwithstanding anything contained herein to the contrary,
      nothing contained herein shall adversely effect the rights of the EMPLOYEE
      and
      his dependents
      and beneficiaries to any and all benefits to which any of them may be entitled
      under the
      benefit plans and arrangements of the Company and/or the Bank in accordance
      with
      the terms
      of
      such benefit plans and arrangements. 

     

     

    IN
      WITNESS WHEREOF, the parties hereto have executed this Agreement as of the
      date
      first written above. 

     

    
      	UNION CENTER NATIONAL
              BANK	 	 	 
	 	 	 	 	 
	By:
              	/s/
              Anthony C.
              Weagley	 	 	 
	Anthony C. Weagley, President
&
              CEO	 	 	
            

    

     

    
      	
              CENTER
                BANCORP, INC.

            	 	 	 
	 	 	 	 	 
	By:
              	/s/
              Anthony C.
              Weagley	 	 	 
	Anthony C. Weagley, President
&
              CEO	 	 	
            

    

     

    
      	
              EMPLOYEE

            	 	 	 
	 	 	 	 	 
	By:
              	/s/
              A. Richard
              Abrahamian 	 	 	 
	A. RICHARD ABRAHAMIAN 	 	 	
            

    

     

    
      
        
        

      

      
        5FORM
      OF INVESTOR WARRANT

    

    Warrant
      No. __________

    

    NEITHER
      THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE
      BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
      COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
      THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY,
      MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
      STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM,
      OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
      SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS
      EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE
      SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY
      AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN
      CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A FINANCIAL INSTITUTION THAT
      IS
      AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES
      ACT.

    

    COMMON
      STOCK PURCHASE WARRANT

    

    YONGYE
      BIOTECHNOLOGY INTERNATIONAL, INC.

     

     

    Warrant
      Shares:      Initial
      Exercise Date: April 17, 2008

    

     

    THIS
      COMMON STOCK PURCHASE WARRANT (the “Warrant”)
      certifies that, for value received, _________________. (the “Holder”)
      is
      entitled, upon the terms and subject to the limitations on exercise and the
      conditions hereinafter set forth, at any time on or after the date hereof (the
      “Initial
      Exercise Date”)
      and on
      or prior to the close of business on the five year anniversary of the Initial
      Exercise Date (the “Termination
      Date”)
      but
      not thereafter, to subscribe for and purchase from Yongye Biotechnology
      International, Inc., a Nevada corporation (the “Company”),
      up to
      ______________ shares (the “Warrant
      Shares”)
      of
      Common Stock. The purchase price of one share of Common Stock under this Warrant
      shall be equal to the Exercise Price, as defined in Section 2(b). 

     

    Section
      1. Definitions.
      Capitalized terms used and not otherwise defined herein shall have the meanings
      set forth in that certain Securities Purchase Agreement (the “Purchase
      Agreement”),
      dated
      of even date herewith, among the Company and the purchasers signatory
      thereto.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    Section
      2. Exercise.

     

    a) Exercise
      of Warrant.
      Exercise of the purchase rights represented by this Warrant may be made, in
      whole or in part, at any time or times on or after the Initial Exercise Date
      and
      on or before the Termination Date by delivery to the Company (or such other
      office or agency of the Company as it may designate by notice in writing to
      the
      registered Holder at the address of the Holder appearing on the books of the
      Company) of a duly executed facsimile copy of the Notice of Exercise Form
      annexed hereto; and, within 3 Trading Days of the date said Notice of Exercise
      is delivered to the Company, the Company shall have received payment of the
      aggregate Exercise Price of the shares thereby purchased by wire transfer or
      cashier’s check drawn on a United States bank. If the exercise is for less than
      all of the Warrant Shares, then the Company shall return to the Holder, together
      with the certificate(s) for the Warrant Shares, a new Warrant certificate for
      the balance of the Warrant Shares. 

     

    b) Exercise
      Price.
      The
      exercise price per share of the Common Stock under this Warrant shall be
      $1.848,
      subject
      to adjustment hereunder (the “Exercise
      Price”);
      provided,
      however,
      after
      the Effective Date, the Company shall have the option to reduce the then
      Exercise Price to any amount for up to 100% of all outstanding
      Warrants.

     

    c) 
      Cashless Exercise.
      If, at
      any time after the first anniversary of the date that this Warrant is issued,
      there is no effective Registration Statement registering, or no current
      prospectus available for, the resale of the Warrant Shares by the Holder, then
      this Warrant may also be exercised at such time by means of a “cashless
      exercise” in which the Holder shall be entitled to receive a certificate for the
      number of Warrant Shares equal to the quotient obtained by dividing [(A-B)
      (X)]
      by (A), where:

     

    (A)
      = the
      VWAP on the Trading Day immediately preceding the date of such
      election;

    

    (B)
      = the
      Exercise Price of this Warrant, as adjusted; and 

    

    (X)
      = the
      number of Warrant Shares issuable upon exercise of this Warrant in accordance
      with the terms of this Warrant by means of a cash exercise rather than a
      cashless exercise.

    

    d) Intentionally
      Omitted. 

     

    e) Mechanics
      of Exercise.
      

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    (i)
      Delivery of Certificates Upon Exercise.
      Certificates for shares purchased hereunder shall be transmitted by the Transfer
      Agent to the Holder by crediting the account of the Holder’s prime broker with
      the Depository Trust Company through its Deposit Withdrawal Agent Commission
      (“DWAC”)
      system
      if the Company is then a participant in such system and either (A) there is
      an
      effective Registration Statement permitting the resale of the Warrant Shares
      by
      the Holder or (B) the shares are eligible for resale without volume or
      manner-of-sale limitations pursuant to Rule 144, and otherwise by physical
      delivery to the address specified by the Holder in the Notice of Exercise within
      3 Trading Days from the delivery to the Company of the Notice of Exercise Form,
      surrender of this Warrant (if required) and payment of the aggregate Exercise
      Price as set forth above (the “Warrant
      Share Delivery Date”).
      This
      Warrant shall be deemed to have been exercised on the date the Exercise Price
      is
      received by the Company. The Warrant Shares shall be deemed to have been issued,
      and Holder or any other person so designated to be named therein shall be deemed
      to have become a holder of record of such shares for all purposes, as of the
      date the Warrant has been exercised by payment to the Company of the Exercise
      Price (or by cashless exercise, if permitted) and all taxes required to be
      paid
      by the Holder, if any, pursuant to Section 2(e)(vi) prior to the issuance of
      such shares, have been paid. If the Company fails for any reason to deliver
      to
      the Holder certificates evidencing the Warrant Shares subject to a Notice of
      Exercise by the Warrant Share Delivery Date, the Company shall pay to the
      Holder, in cash, as liquidated damages and not as a penalty, for each $1,000
      of
      Warrant Shares subject to such exercise (based on the VWAP of the Common Stock
      on the date of the applicable Notice of Exercise), $10 per Trading Day
      (increasing to $20 per Trading Day on the fifth Trading Day after such
      liquidated damages begin to accrue) for each Trading Day after such Warrant
      Share Delivery Date until such certificates are delivered. For purposes hereof,
      the term “VWAP”
shall
      mean, for any date, the price determined by the first of the following clauses
      that applies: (a) if the Common Stock is then listed or quoted on a Trading
      Market, the daily volume weighted average price of the Common Stock for such
      date (or the nearest preceding date) on the Trading Market on which the Common
      Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading
      Day from 9:30 a.m. New York City time to 4:02 p.m. New York City time);
      (b)  if the OTC Bulletin Board is not a Trading Market, the volume weighted
      average price of the Common Stock for such date (or the nearest preceding date)
      on the OTC Bulletin Board; (c) if the Common Stock is not then listed or quoted
      for trading on the OTC Bulletin Board and if prices for the Common Stock are
      then reported in the “Pink Sheets” published by Pink Sheets, LLC (or a similar
      organization or agency succeeding to its functions of reporting prices), the
      most recent bid price per share of the Common Stock so reported; or (d) in
      all other cases, the fair market value of a share of Common Stock as determined
      by an independent appraiser selected in good faith by the Purchasers of a
      majority in interest of the Securities then outstanding and reasonably
      acceptable to the Company, the fees and expenses of which shall be paid by
      the
      Company.

     

    (ii)
      Delivery of New Warrants Upon Exercise.
      If this
      Warrant shall have been exercised in part, the Company shall, at the request
      of
      a Holder and upon surrender of this Warrant certificate, at the time of delivery
      of the certificate or certificates representing Warrant Shares, deliver to
      Holder a new Warrant evidencing the rights of Holder to purchase the unpurchased
      Warrant Shares called for by this Warrant, which new Warrant shall in all other
      respects be identical with this Warrant.

     

    (iii)
      Rescission Rights. If the Company fails to cause the Transfer Agent to transmit
      to the Holder a certificate or the certificates representing the Warrant Shares
      pursuant to Section 2(e)(i) by the Warrant Share Delivery Date, then, the Holder
      will have the right to rescind such exercise.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    (iv)
      Compensation for Buy-In on Failure to Timely Deliver Certificates Upon Exercise.
      In addition to any other rights available to the Holder, if the Company fails
      to
      cause the Transfer Agent to transmit to the Holder a certificate or the
      certificates representing the Warrant Shares pursuant to an exercise on or
      before the Warrant Share Delivery Date, and if after such date the Holder is
      required by its broker to purchase (in an open market transaction or otherwise)
      or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to
      deliver in satisfaction of a sale by the Holder of the Warrant Shares which
      the
      Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company
      shall (A) pay in cash to the Holder the amount by which (x) the Holder’s total
      purchase price (including brokerage commissions, if any) for the shares of
      Common Stock so purchased exceeds (y) the amount obtained by multiplying (1)
      the
      number of Warrant Shares that the Company was required to deliver to the Holder
      in connection with the exercise at issue times (2) the price at which the sell
      order giving rise to such purchase obligation was executed, and (B) at the
      option of the Holder, either reinstate the portion of the Warrant and equivalent
      number of Warrant Shares for which such exercise was not honored or deliver
      to
      the Holder the number of shares of Common Stock that would have been issued
      had
      the Company timely complied with its exercise and delivery obligations
      hereunder. For example, if the Holder purchases Common Stock having a total
      purchase price of $11,000 to cover a Buy-In with respect to an attempted
      exercise of shares of Common Stock with an aggregate sale price giving rise
      to
      such purchase obligation of $10,000, under clause (A) of the immediately
      preceding sentence the Company shall be required to pay the Holder $1,000.
      The
      Holder shall provide the Company written notice indicating the amounts payable
      to the Holder in respect of the Buy-In and, upon request of the Company,
      evidence of the amount of such loss. Nothing herein shall limit a Holder’s right
      to pursue any other remedies available to it hereunder, at law or in equity
      including, without limitation, a decree of specific performance and/or
      injunctive relief with respect to the Company’s failure to timely deliver
      certificates representing shares of Common Stock upon exercise of the Warrant
      as
      required pursuant to the terms hereof.

     

    (v)
      No
      Fractional Shares or Scrip. No fractional shares or scrip representing
      fractional shares shall be issued upon the exercise of this Warrant. As to
      any
      fraction of a share which Holder would otherwise be entitled to purchase upon
      such exercise, the Company shall, at its election, either pay a cash adjustment
      in respect of such final fraction in an amount equal to such fraction multiplied
      by the Exercise Price or round up to the next whole share.

     

    (vi)
      Charges, Taxes and Expenses. Issuance of certificates for Warrant Shares shall
      be made without charge to the Holder for any issue or transfer tax or other
      incidental expense in respect of the issuance of such certificate, all of which
      taxes and expenses shall be paid by the Company, and such certificates shall
      be
      issued in the name of the Holder or in such name or names as may be directed
      by
      the Holder; provided, however, that in the event certificates for Warrant Shares
      are to be issued in a name other than the name of the Holder, this Warrant
      when
      surrendered for exercise shall be accompanied by the Assignment Form attached
      hereto duly executed by the Holder and the Company may require, as a condition
      thereto, the payment of a sum sufficient to reimburse it for any transfer tax
      incidental thereto.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    (vii)
      Closing of Books. The Company will not close its stockholder books or records
      in
      any manner which prevents the timely exercise of this Warrant, pursuant to
      the
      terms hereof.

     

    Section
      3. Certain
      Adjustments.

     

    a) Stock
      Dividends and Splits.
      If the
      Company, at any time while this Warrant is outstanding: (i) pays a stock
      dividend or otherwise make a distribution or distributions on shares of its
      Common Stock or any other equity or equity equivalent securities payable in
      shares of Common Stock (which, for avoidance of doubt, shall not include any
      shares of Common Stock issued by the Company upon exercise of this Warrant),
      (ii) subdivides outstanding shares of Common Stock into a larger number of
      shares, (iii) combines (including by way of reverse stock split) outstanding
      shares of Common Stock into a smaller number of shares or (iv) issues by
      reclassification of shares of the Common Stock any shares of capital stock
      of
      the Company, then in each case the Exercise Price shall be multiplied by a
      fraction of which the numerator shall be the number of shares of Common Stock
      (excluding treasury shares, if any) outstanding immediately before such event
      and of which the denominator shall be the number of shares of Common Stock
      outstanding immediately after such event and the number of shares issuable
      upon
      exercise of this Warrant shall be proportionately adjusted such that the
      aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment
      made pursuant to this Section 3(a) shall become effective immediately after
      the
      record date for the determination of stockholders entitled to receive such
      dividend or distribution and shall become effective immediately after the
      effective date in the case of a subdivision, combination or
      re-classification.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    b) Subsequent
      Equity Sales.
      If the
      Company or any Subsidiary thereof, as applicable, at any time while this Warrant
      is outstanding, shall sell or grant any option to purchase, or sell or grant
      any
      right to reprice, or otherwise dispose of or issue (or announce any offer,
      sale,
      grant or any option to purchase or other disposition) any Common Stock or Common
      Stock Equivalents entitling any Person to acquire shares of Common Stock, at
      an
      effective price per share less than the then Exercise Price (such lower price,
      the “Base
      Share Price”
and
      such issuances collectively, a “Dilutive
      Issuance”)
      (if
      the holder of the Common Stock or Common Stock Equivalents so issued shall
      at
      any time, whether by operation of purchase price adjustments, reset provisions,
      floating conversion, exercise or exchange prices or otherwise, or due to
      warrants, options or rights per share which are issued in connection with such
      issuance, be entitled to receive shares of Common Stock at an effective price
      per share which is less than the Exercise Price, such issuance shall be deemed
      to have occurred for less than the Exercise Price on such date of the Dilutive
      Issuance), then the Exercise Price shall be reduced to a price equal to the
      Base
      Share Price. Such
      adjustment shall be made whenever such Common Stock or Common Stock Equivalents
      are issued. Notwithstanding the foregoing, no adjustments shall be made, paid
      or
      issued under this Section 3(b) in respect of an Exempt Issuance. The Company
      shall notify the Holder, in writing, no later than the Trading Day following
      the
      issuance of any Common Stock or Common Stock Equivalents subject to this Section
      3(b), indicating therein the applicable issuance price, or applicable reset
      price, exchange price, conversion price and other pricing terms (such notice,
      the “Dilutive
      Issuance Notice”).
      

     

    c) Subsequent
      Rights Offerings.
      If the
      Company, at any time while the Warrant is outstanding, shall issue rights,
      options or warrants to all holders of Common Stock (and not to Holders)
      entitling them to subscribe for or purchase shares of Common Stock at a price
      per share less than the VWAP at the record date mentioned below, then, the
      Exercise Price shall be multiplied by a fraction, of which the denominator
      shall
      be the number of shares of the Common Stock outstanding on the date of issuance
      of such rights or warrants plus the number of additional shares of Common Stock
      offered for subscription or purchase, and of which the numerator shall be the
      number of shares of the Common Stock outstanding on the date of issuance of
      such
      rights or warrants plus the number of shares which the aggregate offering price
      of the total number of shares so offered (assuming receipt by the Company in
      full of all consideration payable upon exercise of such rights, options or
      warrants) would purchase at such VWAP. Such adjustment shall be made whenever
      such rights or warrants are issued, and shall become effective immediately
      after
      the record date for the determination of stockholders entitled to receive such
      rights, options or warrants. 

     

    d) Pro
      Rata Distributions.
      If the
      Company, at any time while this Warrant is outstanding, shall distribute to
      all
      holders of Common Stock (and not to Holders of the Warrants) evidences of its
      indebtedness or assets (including cash and cash dividends) or rights or warrants
      to subscribe for or purchase any security other than the Common Stock (which
      shall be subject to Section 3(b)), then in each such case the Exercise Price
      shall be adjusted by multiplying the Exercise Price in effect immediately prior
      to the record date fixed for determination of stockholders entitled to receive
      such distribution by a fraction of which the denominator shall be the VWAP
      determined as of the record date mentioned above, and of which the numerator
      shall be such VWAP on such record date less the then per share fair market
      value
      at such record date of the portion of such assets or evidence of indebtedness
      so
      distributed applicable to one outstanding share of the Common Stock as
      determined by the Board of Directors in good faith. In either case the
      adjustments shall be described in a statement provided to the Holder of the
      portion of assets or evidences of indebtedness so distributed or such
      subscription rights applicable to one share of Common Stock. Such adjustment
      shall be made whenever any such distribution is made and shall become effective
      immediately after the record date mentioned above.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    e) Fundamental
      Transaction.
      If, at
      any time while this Warrant is outstanding, (i) the Company effects any merger
      or consolidation of the Company with or into another Person, (ii) the Company
      effects any sale of all or substantially all of its assets in one or a series
      of
      related transactions, (iii) any tender offer or exchange offer (whether by
      the
      Company or another Person) is completed pursuant to which holders of Common
      Stock are permitted to tender or exchange their shares for other securities,
      cash or property or (iv) the Company effects any reclassification of the Common
      Stock or any compulsory share exchange pursuant to which the Common Stock is
      effectively converted into or exchanged for other securities, cash or property
      (each “Fundamental
      Transaction”),
      then,
      upon any subsequent exercise of this Warrant, the Holder shall have the right
      to
      receive, for each Warrant Share that would have been issuable upon such exercise
      immediately prior to the occurrence of such Fundamental Transaction, the number
      of shares of Common Stock of the successor or acquiring corporation or of the
      Company, if it is the surviving corporation, and any additional consideration
      (the “Alternate
      Consideration”)
      receivable as a result of such merger, consolidation or disposition of assets
      by
      a holder of the number of shares of Common Stock for which this Warrant is
      exercisable immediately prior to such event. For purposes of any such exercise,
      the determination of the Exercise Price shall be appropriately adjusted to
      apply
      to such Alternate Consideration based on the amount of Alternate Consideration
      issuable in respect of one share of Common Stock in such Fundamental
      Transaction, and the Company shall apportion the Exercise Price among the
      Alternate Consideration in a reasonable manner reflecting the relative value
      of
      any different components of the Alternate Consideration. If holders of Common
      Stock are given any choice as to the securities, cash or property to be received
      in a Fundamental Transaction, then the Holder shall be given the same choice
      as
      to the Alternate Consideration it receives upon any exercise of this Warrant
      following such Fundamental Transaction. To the extent necessary to effectuate
      the foregoing provisions, any successor to the Company or surviving entity
      in
      such Fundamental Transaction shall issue to the Holder a new warrant consistent
      with the foregoing provisions and evidencing the Holder’s right to exercise such
      warrant into Alternate Consideration. The terms of any agreement pursuant to
      which a Fundamental Transaction is effected shall include terms requiring any
      such successor or surviving entity to comply with the provisions of this Section
      3(e) and insuring that this Warrant (or any such replacement security) will
      be
      similarly adjusted upon any subsequent transaction analogous to a Fundamental
      Transaction. Notwithstanding anything to the contrary, in the event of a
      Fundamental Transaction that is (1) an all cash transaction, (2) a “Rule 13e-3
      transaction” as defined in Rule 13e-3 under the Exchange Act, or (3) a
      Fundamental Transaction involving a person or entity not traded on a national
      securities exchange, the Nasdaq Global Select Market, the Nasdaq Global Market,
      or the Nasdaq Capital Market, the Company or any successor entity shall pay
      at
      the Holder’s option, exercisable at any time concurrently with or within 30 days
      after the consummation of the Fundamental Transaction, an amount of cash equal
      to the value of this Warrant as determined in accordance with the Black Scholes
      Option Pricing Model obtained from the “OV” function on Bloomberg L.P. using (A)
      a price per share of Common Stock equal to the VWAP of the Common Stock for
      the
      Trading Day immediately preceding the date of consummation of the applicable
      Fundamental Transaction, (B) a risk-free interest rate corresponding to the
      U.S.
      Treasury rate for a 30 day period immediately prior to the consummation of
      the
      applicable Fundamental Transaction, (C) an expected volatility equal to the
      100
      day volatility obtained from the “HVT” function on Bloomberg L.P. determined as
      of the Trading Day immediately following the public announcement of the
      applicable Fundamental Transaction and (D) a remaining option time equal to
      the
      time between the date of the public announcement of such transaction and the
      Termination Date. 

     

    f) Calculations.
      All
      calculations under this Section 3 shall be made to the nearest cent or the
      nearest 1/100th of a share, as the case may be. For purposes of this Section
      3,
      the number of shares of Common Stock deemed to be issued and outstanding as
      of a
      given date shall be the sum of the number of shares of Common Stock (excluding
      treasury shares, if any) issued and outstanding.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    g) Notice
      to Holder.
      

     

    i. Adjustment
      to Exercise Price.
      Whenever the Exercise Price is adjusted pursuant to any provision of this
      Section 3, the Company shall promptly mail to the Holder a notice setting forth
      the Exercise Price after such adjustment and setting forth a brief statement
      of
      the facts requiring such adjustment. If the Company enters into a Future Priced
      Securities Transaction, despite the prohibition thereon in the Purchase
      Agreement, the Company shall be deemed to have issued Common Stock or Common
      Stock Equivalents at the lowest possible conversion or exercise price at which
      such securities may be converted or exercised. 

     

    ii. Notice
      to Allow Exercise by Holder.
      If (A)
      the Company shall declare a dividend (or any other distribution in whatever
      form) on the Common Stock, (B) the Company shall declare a special nonrecurring
      cash dividend on or a redemption of the Common Stock, (C) the Company shall
      authorize the granting to all holders of the Common Stock rights or warrants
      to
      subscribe for or purchase any shares of capital stock of any class or of any
      rights, (D) the approval of any stockholders of the Company shall be required
      in
      connection with any reclassification of the Common Stock, any consolidation
      or
      merger to which the Company is a party, any sale or transfer of all or
      substantially all of the assets of the Company, of any compulsory share exchange
      whereby the Common Stock is converted into other securities, cash or property,
      or (E) the Company shall authorize the voluntary or involuntary dissolution,
      liquidation or winding up of the affairs of the Company, then, in each case,
      the
      Company shall cause to be mailed to the Holder at its last address as it shall
      appear upon the Warrant Register of the Company, at least 20 calendar days
      prior
      to the applicable record or effective date hereinafter specified, a notice
      stating (x) the date on which a record is to be taken for the purpose of such
      dividend, distribution, redemption, rights or warrants, or if a record is not
      to
      be taken, the date as of which the holders of the Common Stock of record to
      be
      entitled to such dividend, distributions, redemption, rights or warrants are
      to
      be determined or (y) the date on which such reclassification, consolidation,
      merger, sale, transfer or share exchange is expected to become effective or
      close, and the date as of which it is expected that holders of the Common Stock
      of record shall be entitled to exchange their shares of the Common Stock for
      securities, cash or other property deliverable upon such reclassification,
      consolidation, merger, sale, transfer or share exchange; provided that the
      failure to mail such notice or any defect therein or in the mailing thereof
      shall not affect the validity of the corporate action required to be specified
      in such notice. The Holder is entitled to exercise this Warrant during the
      period commencing on the date of such notice to the effective date of the event
      triggering such notice.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    Section
      4. Transfer
      of Warrant.

     

    a) Transferability.
      Subject
      to compliance with any applicable securities laws and the conditions set forth
      in Section 4(d) hereof and to the provisions of the Purchase Agreement, this
      Warrant and all rights hereunder (including, without limitation, any
      registration rights) are transferable, in whole or in part, upon surrender
      of
      this Warrant at the principal office of the Company or its designated agent,
      together with a written assignment of this Warrant substantially in the form
      attached hereto duly executed by the Holder or its agent or attorney and funds
      sufficient to pay any transfer taxes payable upon the making of such transfer.
      Upon such surrender and, if required, such payment, the Company shall execute
      and deliver a new Warrant or Warrants in the name of the assignee or assignees,
      as applicable, and in the denomination or denominations specified in such
      instrument of assignment, and shall issue to the assignor a new Warrant
      evidencing the portion of this Warrant not so assigned, and this Warrant shall
      promptly be cancelled. The Warrant, if properly assigned, may be exercised
      by a
      new holder for the purchase of Warrant Shares without having a new Warrant
      issued. 

     

    b) New
      Warrants.
      This
      Warrant may be divided or combined with other Warrants upon presentation hereof
      at the aforesaid office of the Company, together with a written notice
      specifying the names and denominations in which new Warrants are to be issued,
      signed by the Holder or its agent or attorney. Subject to compliance with
      Section 4(a), as to any transfer which may be involved in such division or
      combination, the Company shall execute and deliver a new Warrant or Warrants
      in
      exchange for the Warrant or Warrants to be divided or combined in accordance
      with such notice. All Warrants issued on transfers or exchanges shall be dated
      the original Issue Date and shall be identical with this Warrant except as
      to
      the number of Warrant Shares issuable pursuant thereto. 

     

    c) Warrant
      Register.
      The
      Company shall register this Warrant, upon records to be maintained by the
      Company for that purpose (the “Warrant
      Register”),
      in
      the name of the record Holder hereof from time to time. The Company may deem
      and
      treat the registered Holder of this Warrant as the absolute owner hereof for
      the
      purpose of any exercise hereof or any distribution to the Holder, and for all
      other purposes, absent actual notice to the contrary.

     

      d) Transfer
        Restrictions.
        If,
        at the
time
        of
        the surrender of this Warrant in connection with any transfer of this Warrant,
        the transfer of this Warrant shall not be either (i) registered pursuant
        to an
        effective registration
        statement under the Securities Act
        and
under
        applicable state securities or blue sky laws or (ii) eligible for resale
        without
        volume or manner-of-sale restrictions pursuant to Rule 144, the Company may
        require, as a condition of allowing such transfer, that the Holder or transferee
        of this Warrant, as the case may be, comply
        with the provisions of Section 5.7 of the Purchase Agreement.

     

    Section
      5. Miscellaneous.

     

    a) No
      Rights as Stockholder Until Exercise.
      This
      Warrant does not entitle the Holder to any voting rights or other rights as
      a
      stockholder of the Company prior to the exercise hereof as set forth in Section
      2(e)(i). 

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    b) Loss,
      Theft, Destruction or Mutilation of Warrant.
      The
      Company covenants that upon receipt by the Company of evidence reasonably
      satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
      or any stock certificate relating to the Warrant Shares, and in case of loss,
      theft or destruction, of indemnity or security reasonably satisfactory to it
      (which, in the case of the Warrant, shall not include the posting of any bond),
      and upon surrender and cancellation of such Warrant or stock certificate, if
      mutilated, the Company will make and deliver a new Warrant or stock certificate
      of like tenor and dated as of such cancellation, in lieu of such Warrant or
      stock certificate.

     

    c) Saturdays,
      Sundays, Holidays, etc.
      If the
      last or appointed day for the taking of any action or the expiration of any
      right required or granted herein shall not be a Business Day, then, such action
      may be taken or such right may be exercised on the next succeeding Business
      Day.

     

    d) Authorized
      Shares.
      

     

    The
      Company covenants that, during the period the Warrant is outstanding, it will
      reserve from its authorized and unissued Common Stock a sufficient number of
      shares to provide for the issuance of the Warrant Shares upon the exercise
      of
      any purchase rights under this Warrant. The Company further covenants that
      its
      issuance of this Warrant shall constitute full authority to its officers who
      are
      charged with the duty of executing stock certificates to execute and issue
      the
      necessary certificates for the Warrant Shares upon the exercise of the purchase
      rights under this Warrant. The Company will take all such reasonable action
      as
      may be necessary to assure that such Warrant Shares may be issued as provided
      herein without violation of any applicable law or regulation, or of any
      requirements of the Trading Market upon which the Common Stock may be listed.
      The Company covenants that all Warrant Shares which may be issued upon the
      exercise of the purchase rights represented by this Warrant will, upon exercise
      of the purchase rights represented by this Warrant, be duly authorized, validly
      issued, fully paid and nonassessable and free from all taxes, liens and charges
      created by the Company in respect of the issue thereof (other than taxes in
      respect of any transfer occurring contemporaneously with such issue).

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

     

    Except
      and to the extent as waived or consented to by the Holder, the Company shall
      not
      by any action, including, without limitation, amending its certificate of
      incorporation or through any reorganization, transfer of assets, consolidation,
      merger, dissolution, issue or sale of securities or any other voluntary action,
      avoid or seek to avoid the observance or performance of any of the terms of
      this
      Warrant, but will at all times in good faith assist in the carrying out of
      all
      such terms and in the taking of all such actions as may be necessary or
      appropriate to protect the rights of Holder as set forth in this Warrant against
      impairment. Without limiting the generality of the foregoing, the Company will
      (i) not increase the par value of any Warrant Shares above the amount payable
      therefor upon such exercise immediately prior to such increase in par value,
      (ii) take all such action as may be necessary or appropriate in order that
      the
      Company may validly and legally issue fully paid and nonassessable Warrant
      Shares upon the exercise of this Warrant and (iii) use commercially reasonable
      efforts to obtain all such authorizations, exemptions or consents from any
      public regulatory body having jurisdiction thereof, as may be, necessary to
      enable the Company to perform its obligations under this Warrant.

     

    Before
      taking any action which would result in an adjustment in the number of Warrant
      Shares for which this Warrant is exercisable or in the Exercise Price, the
      Company shall obtain all such authorizations or exemptions thereof, or consents
      thereto, as may be necessary from any public regulatory body or bodies having
      jurisdiction thereof.

     

    e) Jurisdiction.
      All
      questions concerning the construction, validity, enforcement and interpretation
      of this Warrant shall be determined in accordance with the provisions of the
      Purchase Agreement.

     

    f) Restrictions.
      The
      Holder acknowledges that the Warrant Shares acquired upon the exercise of this
      Warrant, if not registered, will have restrictions upon resale imposed by state
      and federal securities laws.

     

    g) Nonwaiver
      and Expenses.
      No
      course of dealing or any delay or failure to exercise any right hereunder on
      the
      part of Holder shall operate as a waiver of such right or otherwise prejudice
      Holder’s rights, powers or remedies, notwithstanding the fact that all rights
      hereunder terminate on the Termination Date. If the Company willfully and
      knowingly fails to comply with any provision of this Warrant, which results
      in
      any material damages to the Holder, the Company shall pay to Holder such amounts
      as shall be sufficient to cover any costs and expenses including, but not
      limited to, reasonable attorneys’ fees, including those of appellate
      proceedings, incurred by Holder in collecting any amounts due pursuant hereto
      or
      in otherwise enforcing any of its rights, powers or remedies
      hereunder.

     

    h) Notices.
      Any
      notice, request or other document required or permitted to be given or delivered
      to the Holder by the Company shall be delivered in accordance with the notice
      provisions of the Purchase Agreement.

     

    i) Limitation
      of Liability.
      No
      provision hereof, in the absence of any affirmative action by Holder to exercise
      this Warrant to purchase Warrant Shares, and no enumeration herein of the rights
      or privileges of Holder, shall give rise to any liability of Holder for the
      purchase price of any Common Stock or as a stockholder of the Company, whether
      such liability is asserted by the Company or by creditors of the
      Company.

     

    j) Remedies.
      The
      Holder, in addition to being entitled to exercise all rights granted by law,
      including recovery of damages, will be entitled to specific performance of
      its
      rights under this Warrant. The Company agrees that monetary damages would not
      be
      adequate compensation for any loss incurred by reason of a breach by it of
      the
      provisions of this Warrant and hereby agrees to waive and not to assert the
      defense in any action for specific performance that a remedy at law would be
      adequate.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

     

    k) Successors
      and Assigns.
      Subject
      to applicable securities laws, this Warrant and the rights and obligations
      evidenced hereby shall inure to the benefit of and be binding upon the
      successors of the Company and the successors and permitted assigns of Holder.
      The provisions of this Warrant are intended to be for the benefit of all Holders
      from time to time of this Warrant and shall be enforceable by the Holder or
      holder of Warrant Shares.

     

    l) Amendment.
      This
      Warrant may be modified or amended or the provisions hereof waived with the
      written consent of the Company and Holders holding Warrants at least equal
      to
      67% of the Warrant Shares issuable upon exercise of all then outstanding
      Warrants.

     

    m) Severability.
      Wherever possible, each provision of this Warrant shall be interpreted in such
      manner as to be effective and valid under applicable law, but if any provision
      of this Warrant shall be prohibited by or invalid under applicable law, such
      provision shall be ineffective to the extent of such prohibition or invalidity,
      without invalidating the remainder of such provisions or the remaining
      provisions of this Warrant.

     

    n) Headings.
      The
      headings used in this Warrant are for the convenience of reference only and
      shall not, for any purpose, be deemed a part of this Warrant.

     

    

    ********************

    

    

    (Signature
      Pages Follow)

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    

    IN
      WITNESS WHEREOF, the Company has caused this Warrant to be executed by its
      officer thereunto duly authorized as of the date first above
      indicated.

     

    

     

    
      	
              YONGYE
                BIOTECHNOLOGY INTERNATIONAL, INC.

               

            
	
              By:__________________________________________

              Name:
                Zishen Wu

              Title:
                CEO

            

    

    

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    NOTICE
      OF EXERCISE

    

    TO:
      YONGYE
      BIOTECHNOLOGY INTERNATIONAL, INC.

     

      (1)The
      undersigned hereby elects to purchase ________ Warrant Shares of the Company
      pursuant to the terms of the attached Warrant (only if exercised in full),
      and
      tenders herewith payment of the exercise price in full, together with all
      applicable transfer taxes, if any.

     

    Payment
      shall take the form of wire transfer or certified check in lawful money of
      the
      United States

     

    .

     

      (2)Please
      issue a certificate or certificates representing said Warrant Shares in the
      name
      of the undersigned or in such other name as is specified below:

     

    _______________________________

     

    

    The
      Warrant Shares shall be delivered to the following DWAC Account Number or by
      physical delivery of a certificate to:

    

    _______________________________

     

    _______________________________

     

    _______________________________

    

    (4)
      Accredited
      Investor.
      The
      undersigned is an “accredited investor” as defined in Regulation D promulgated
      under the Securities Act of 1933, as amended.

    

    [SIGNATURE
      OF HOLDER]

     

    Name
      of
      Investing Entity:
      ________________________________________________________________________

    Signature
      of Authorized Signatory of Investing Entity:
      _________________________________________________

    Name
      of
      Authorized Signatory:
      ___________________________________________________________________

    Title
      of
      Authorized Signatory:
      ____________________________________________________________________

    Date:
      ________________________________________________________________________________________

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

     

    ASSIGNMENT
      FORM

    

    (To
      assign the foregoing warrant, execute

    this
      form
      and supply required information. 

    Do
      not
      use this form to exercise the warrant.)

    

    

    

    FOR
      VALUE
      RECEIVED, [____] all of or [_______] shares of the foregoing Warrant and all
      rights evidenced thereby are hereby assigned to

     

    

    _______________________________________________
      whose address is

    

    _______________________________________________________________.

    

    

    

    _______________________________________________________________

    

    Dated:
      ______________, _______

    

    

    Holder’s
      Signature: _____________________________

    

    Holder’s
      Address: _____________________________

     

    _____________________________

    

    

    

    Signature
      Guaranteed: ___________________________________________

    

    

    NOTE:
      The
      signature to this Assignment Form must correspond with the name as it appears
      on
      the face of the Warrant, without alteration or enlargement or any change
      whatsoever, and must be guaranteed by a bank or trust company. Officers of
      corporations and those acting in a fiduciary or other representative capacity
      should file proper evidence of authority to assign the foregoing
      Warrant.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}]]